IMPORTANT NOTICE | Mayberry Investments Limited is a cashless institution.

Mayberry Investments Limited is a cashless institution.
Please note that cash deposits into any Mayberry account held at commercial banks, whether made in-branch or via Automated Banking Machines (ABMs), are not accepted and will not be processed. For information on accepted payment methods, please contact your Investment Advisor.

Germany’s inflation rate expected to rise by 0.3% for September 2023

September 28, 2023

 

According to the Federal Statistical Office (Destatis), Germany is expected to experience the lowest inflation level since the war in Ukraine began. The inflation rate in September 2023 is anticipated to be +4.5% relative to September 2022. Notably, the last time a lower inflation rate was registered was in February 2022, when it stood at +4.3%. The inflation rate in August 2023 was +6.1%. Based on data provided so far, Destatis predicts that consumer prices will increase by 0.3% for the month of September 2023, as it did in August. Core inflation in September is expected to be +4.6% (August 2023: +5.5%).

Food prices continued to rise at a faster-than-average rate (+7.5%) in September 2023 relative to September 2022. However, the increase in energy prices, at +1.0%, was significantly smaller than the year-on-year change rate of the overall index. One of the factors is a base effect compared with September 2022, which was influenced by the Federal Government’s elimination of the fuel discount, which was a part of their relief package. Additionally, the discontinuation of the 9-euro ticket in September 2022, which was available from June through August 2022, has a base effect on the growth of prices in the services sector, which rose +4.0% on the same month of the preceding year.

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_453968572
June 15, 2026   Jamaica Stock Exchange Limited (JSE) has advised that the Company is managing a cybersecurity incident that was recently id…
shutterstock_453968572
June 15, 2026   Scotia Group Jamaica Limited (SGJ) has advised of the following appointments to the Board of Directors of the Company and i…
shutterstock_453968572
June 15, 2026   Eppley Limited (EPLY) has advised that Mr. Maxim Rochester has resigned as a Director of the Company and Chairman of the Au…
shutterstock_148562033
June 15, 2026   Supreme Ventures Limited (SVL) has advised that during the period June 11 to 12, 2026, a related entity purchased a total o…
shutterstock_148562033
June 15, 2026   Dolla Financial Services Limited (DOLLA) has advised that Mayberry Holdings Limited (MHL) and Mayberry Jamaican Equities Li…
shutterstock_316932977-700x441
June 15, 2026 Guyana is expected to remain one of the strongest-performing economies in the Caribbean and wider Latin American region as expandin…
shutterstock_537598660
June 15, 2026 The Limners and Bards Limited (LAB) Unaudited financials for the six months ended April 30, 2026: The Limners and Bards Limited (LAB)…
shutterstock_537598660
June 15, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the six months ended April 30, 2026: Indies Pharma Jamaica Limi…